Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when COCH files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsEnvoy Medical reports Q1 2026 earnings; full results in press release
Filed May 11, 2026 · Period ending May 11, 2026 · ~1 min read
Key Changes
-
medium
Envoy Medical disclosed financial results for the quarter ended March 31, 2026 via press release. The 8-K filing itself does not contain specific figures—investors must review Exhibit 99.1 for revenue, earnings, and other metrics.
Item 2.02 verify on EDGAR → -
low
The filing references a press release dated March 11, 2026 as an exhibit, but provides no detail on its content within the 8-K body. This is a standard procedural disclosure.
Exhibit 99.1 view on EDGAR →
Summary
Envoy Medical filed an 8-K on May 11, 2026 to announce its first-quarter 2026 financial results. The company issued a press release covering the period ended March 31, 2026, but the 8-K itself does not include specific revenue, profit, or loss figures—those details are contained in the attached press release (Exhibit 99.1). This is a routine earnings disclosure format common among public companies.
For retail investors, the key takeaway is that Q1 results are now public, but you'll need to review the full press release to understand performance trends, guidance, and management commentary. The filing also references a separate press release dated March 11, 2026, though its subject matter is not disclosed in the 8-K body. Watch for any follow-on 10-Q filing, which will provide audited financials and management discussion of quarterly performance.
Section-by-Section Diff
Event · Item 2.02 — Results of Operations and Financial Condition
Item 2.02 — Results of Operations and Financial Condition filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On May 11, 2026, Envoy Medical, Inc. (the “Company”), issued a press release regarding the Company’s financial results for its fiscal quarter ended March 31, 2026.
The company disclosed its financial results for the quarter ended March 31, 2026 through a press release. The 8-K itself does not contain the actual financial figures; those are in the attached press release (Exhibit 99.1). This is a standard earnings announcement filing.
Event · Item 9.01 — Financial Statements and Exhibits
Item 9.01 — Financial Statements and Exhibits filed; see Key Changes for terms.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
99.1
Press Release dated March 11, 2026
The 8-K references a press release dated March 11, 2026 as Exhibit 99.1. The filing body does not disclose the content or subject matter of the press release, making it impossible to assess materiality from this 8-K alone. This is a procedural filing listing exhibits without substantive disclosure.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify